However, neither ERG nor AR possess clustered promoter binding sites in the promoter of the MCOLN2 gene and, therefore, MCOLN2 up-regulation in prostate cancers with ERG over-expression is not directly performed by these transcription factors. The gene discussed is MCOLN2; the disease is prostate cancer.